Julie O'Neill, EVP Global Operations at ALEXION PHARMACEUTICALS INC (ALXN), sold 11,160 shares at $140.00 ($1.6M) on 2017-08-28, disclosed to the SEC on 2017-08-30.
Scheduled sale ($1.6M) by EVP Global Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| ALXN | SELL | 2018-02-08 | $557K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $248K | — | Filing → |
| ALXN | SELL | 2017-09-05 | $636K | — | Filing → |